|7994144||Process for the preparation of a composition of genetically modified hematopoietic progenitor cells|
Described are compositions and methods relating to gene therapy, particularly as applied to hematopoietic progenitor (HP) cells, to transduced cells and methods of obtaining them, and to methods of using them to provide prolonged engraftment of modified hematopoieti...
|6114167||Ribozymes targeting the MoMLV PSI packaging sequence and the HIV tat sequence|
A cell comprising a synthetic non-naturally occurring oligonucleotide compound comprises nucleotides whose sequence defines a conserved catalytic region and nucleotides whose sequence hybridizes with a predetermined target sequence within a MoMLV Psi pack...
|5712384||Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs|
This invention is directed to a synthetic non-naturally occurring oligonucleotide compound which comprises nucleotides whose sequence defines a conserved catalytic region and nucleotides whose sequence is capable of hybridizing with a predetermined target...